MedPage Today invited specialists from leading medical institutions to weigh in on the latest advancements in hepatitis C with one question each day for 10 days. In this installment, we asked “Who is at risk and how can they be reached?”
Our participants are:
Robin D. Kim, MD, associate professor of surgery, University of Utah Health Care
Anthony D. Martinez, MD, clinical associate professor, University at Buffalo Department of Medicine
Fred Poordad, MD, clinical professor of medicine, The University of Texas Health Science Center at San Antonio
Source: Who is at risk and how can they be reached?
Author Info
